Sasaki, Y., Tamura, T., Eguchi, K., Shinkai, T., Fujiwara, Y., Fukuda, M., Ohe, Y., Bungo, M., Horichi, N., Niimi, S., Minato, K. and Nakagawa, K. (1989) Pharmacokinetics of (Glycolate-0,0’)-Diammine Platinum (II), a New Platinum Derivative, in Comparison with Cisplatin and Carboplatin. Cancer Chemotherapy and Pharmacology, 23, 243-246. http://dx.doi.org/10.1007/BF00451649

has been cited by the following article:

• TITLE: Feasibility of Outpatient Chemotherapy with S-1 and Cisplatin for Gastric Cancer

  AUTHORS: Hironaga Satake, Akihito Tsuji, Takeshi Kotake, Mikio Fujita

  KEYWORDS: Gastric Cancer, Cisplatin, S-1, Short Hydration, Outpatient Chemotherapy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.8, July 7, 2014

  ABSTRACT: Objective: To evaluate the feasibility of S-1 and high-dose cisplatin short hydration regimens for outpatients with unresectable metastatic gastric cancer. Methods: Data for individual outpatients treated in our institution were retrospectively pooled to assess the feasibility of an S-1 and highdose cisplatin short hydration regimen (S-1: 80 to 120 mg on Days 1 to 21; cisplatin: 60 mg/m2on Day 8, every 5 weeks), which included 2250 ml of intravenous fluids and 1000 ml oral hydration. Ten consecutive patients were treated with S-1 and high-dose cisplatin short hydration for unresectable metastatic gastric cancer from July 2011 to May 2012 and were included in the analysis. Results: With a median of 3.5 medication cycles, unscheduled admission occurred in two patients for 5 days each due to paralytic ileus and cerebral infarction. Four patients required dose reduction, in both S-1 and cisplatin in two patients, and in S-1 alone and cisplatin alone in one patient each. Renal function transiently declined after administration of cisplatin, but serum creatinine level and estimated glomerular filtration rate were both improved by the time of the next administration. Conclusion: This study suggests that an S-1 and high-dose cisplatin short hydration strategy for outpatients with unresectable metastatic gastric cancer might be feasible.